 |
 |
 |
 |
|
 |
Treatment
|
 |
Location |
 |
Last Updated |
 |
 |
 |
Details |
 |
ABTC07-01-Phase I Trial of Aflibercept (VEGF Trap) with Radiation Therapy and Concomitant and Adjuvant
Temozolomide in Patients with Malignant Glioma |
 |
San Francisco, CA |
 |
07/07/2009 |
 |
 |
 |
 |
 |
Details |
 |
PHASE II, single-arm, open-label investigation of HSPPC-96 vaccine with concurrent temozolomide in patients with newly diagnosed Glioblastoma Multiforme |
 |
San Francisco, CA |
 |
07/07/2009 |
 |
 |
 |
Details |
 |
A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas |
 |
San Francisco, CA |
 |
04/06/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Trial of RAD001 in Patients with Recurrent Low Grade Glioma |
 |
San Francisco, CA |
 |
04/06/2009 |
 |
 |
 |
Details |
 |
A Phase II study of Bevacizumab (Avastin?) plus Temodar and Tarceva during and after Radiation Therapy in patients with newly diagnosed Glioblastoma or Gliosarcoma |
 |
San Francisco, CA |
 |
01/09/2009 |
 |
 |
 |
 |
 |
Details |
 |
NABTC05-02 - Phase I/II Studies of BAY 43-9006 (sorafenib) in Combination with OSI-774 (erlotinib), R115777 (tipifarnib) or CCI-779 (temsirolimus) in Patients with Recurrent Glioblastoma Multiforme or Gliosarcoma. |
 |
San Francisco, CA |
 |
01/09/2009 |
 |
 |
 |
Details |
 |
Phase II Study Of 7 Days On/7 Days Off Temozolomide In Patients With High-Grade Glioma |
 |
San Francisco, CA |
 |
01/17/2008 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of Temozolomide (temodar) in the Treatment of Adult Patients with
Supratentorial Low Grade Glioma |
 |
San Francisco, CA |
 |
10/03/2007 |
 |
 |
 |
Details |
 |
NABTC 04-03: A Phase I Study of Vorinostat (Suberolyanilide Hydroxamic Acid [SAHA]) in Combination with Temozolomide in Patients with Malignant Gliomas |
 |
San Francisco, CA |
 |
10/03/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine For Patients With Recurrent High Grade Glioma |
 |
San Francisco, CA |
 |
10/03/2007 |
 |
 |
 |
Details |
 |
Phase II Study of Temozolomide in Patients With Supratentorial Low-Grade Glioma |
 |
San Francisco, CA |
 |
05/02/2006 |
 |
 |
 |
 |
 |